Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir

Published:2012-09 Issue:3 Volume:143 Page:608-618.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Poordad Fred,Bronowicki Jean–Pierre,Gordon Stuart C.,Zeuzem Stefan,Jacobson Ira M.,Sulkowski Mark S.,Poynard Thierry,Morgan Timothy R.,Molony Cliona,Pedicone Lisa D.,Sings Heather L.,Burroughs Margaret H.,Sniukiene Vilma,Boparai Navdeep,Goteti Venkata S.,Brass Clifford A.,Albrecht Janice K.,Bacon Bruce R.

Funder

Abbott Laboratories

GlaxoSmithKline

Merck

Roche

Bayer

Bristol-Myers Squibb

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference14 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

3. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

4. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin;Ferenci;J Hepatol,2005

5. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients;Heliyon;2022-08

2. Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients;Genes & Diseases;2020-09

3. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities;Expert Review of Precision Medicine and Drug Development;2020-06-09

4. Sofosbuvir-/Daclatasvir-based therapy for chronic HCV and HCV/hepatitis B virus coinfected patients in Egypt;Transactions of The Royal Society of Tropical Medicine and Hygiene;2019-11-12

5. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients;Expert Review of Gastroenterology & Hepatology;2019-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3